AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2012
Dec 14, 2012
31542_dirs_2012-12-14_31a6a188-48df-43ef-9c6d-19d30b4ac45b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2012-12-12
Reporting Person: Winship M Douglas (VP, Regulatory Operations)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-12 | Options to purchase common stock | $0.47 | A | 25000 | Acquired | 2017-12-12 | Common Stock (25000) | Direct |
| 2012-12-12 | Options to purchase common stock | $0.47 | A | 25000 | Acquired | 2017-12-12 | Common Stock (25000) | Direct |
| 2012-12-12 | Options to purchase common stock | $0.47 | A | 25000 | Acquired | 2017-12-12 | Common Stock (25000) | Direct |
More from CATALYST PHARMACEUTICALS, INC.
M&A Activity
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Earnings Release
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6